Study of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Newborns Exposed to HIV
Study of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Newborns Exposed to HIV
Active, not recruiting · NCT07055451 · Registry updated 2026-08-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Newborns Exposed to HIV | HIV-1-infection | Active, not recruiting | Phase 1 | 2026-08-26 | NCT07055451 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Gilead Sciences | 180 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Family Centre for Research with Ubuntu (FAMCRU) | Cape Town | South Africa | 1 |
| Grady Health System - Ponce de Leon Center | Atlanta | United States | 1 |
| Perinatal HIV Research Unit (PHRU) | Gauteng | South Africa | 1 |
| Ronald Reagan UCLA Medical Center (inpatient hospital) | Los Angeles | United States | 2 |
| St Jude Children's Research Hospital | Memphis | United States | 10 |
| WITS RHI Shandukani Research Centre | Johannesburg | South Africa | 1 |